Global Tumor NGS Detection Kit Market Growth 2023-2029

Global Tumor NGS Detection Kit Market Growth 2023-2029

The global Tumor NGS Detection Kit market size is projected to grow from US$ 857.9 million in 2022 to US$ 2513.5 million in 2029; it is expected to grow at a CAGR of 16.6% from 2023 to 2029.

United States market for Tumor NGS Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Tumor NGS Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Tumor NGS Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Tumor NGS Detection Kit players cover Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific, Memorial Sloan Kettering, Novogene, Geneseeq, AmoyDx and Burning Rock Medicine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Tumor NGS detection kit is an experimental consumable used in tumor detection

LPI (LP Information)' newest research report, the “Tumor NGS Detection Kit Industry Forecast” looks at past sales and reviews total world Tumor NGS Detection Kit sales in 2022, providing a comprehensive analysis by region and market sector of projected Tumor NGS Detection Kit sales for 2023 through 2029. With Tumor NGS Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor NGS Detection Kit industry.

This Insight Report provides a comprehensive analysis of the global Tumor NGS Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor NGS Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tumor NGS Detection Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor NGS Detection Kit and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor NGS Detection Kit.

This report presents a comprehensive overview, market shares, and growth opportunities of Tumor NGS Detection Kit market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing

Segmentation by application
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Foundation Medicine
Illumina Inc.
Life Technologies Corporation
Thermo Fisher Scientific
Memorial Sloan Kettering
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
NantHealth
Personal Genome Diagnostics
GTH.O

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tumor NGS Detection Kit market?

What factors are driving Tumor NGS Detection Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tumor NGS Detection Kit market opportunities vary by end market size?

How does Tumor NGS Detection Kit break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.